.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Express Scripts
Federal Trade Commission
Deloitte
Healthtrust
Accenture
Colorcon
UBS
Julphar
Mallinckrodt

Generated: September 26, 2017

DrugPatentWatch Database Preview

IMATINIB MESYLATE Drug Profile

« Back to Dashboard

What is the patent landscape for Imatinib Mesylate, and what generic Imatinib Mesylate alternatives are available?

Imatinib Mesylate is a drug marketed by Sun Pharma Global, Mylan Pharms Inc, Apotex Inc, and Teva Pharms Usa. and is included in four NDAs.

The generic ingredient in IMATINIB MESYLATE is imatinib mesylate. There are thirty-one drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the imatinib mesylate profile page.

Summary for Tradename: IMATINIB MESYLATE

Patents:0
Applicants:4
NDAs:4
Suppliers / Packagers: see list7
Bulk Api Vendors: see list101
Clinical Trials: see list790
Patent Applications: see list8,443
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:IMATINIB MESYLATE at DailyMed

Pharmacology for Tradename: IMATINIB MESYLATE

Drug ClassKinase Inhibitor
Mechanism of ActionProtein Kinase Inhibitors
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Covington
Merck
Medtronic
QuintilesIMS
Fish and Richardson
Harvard Business School
Healthtrust
Daiichi Sankyo
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot